1 Product identity
Complete for Women Over 50
Other Combinations Tablet or Pill 74 ingredients DSLD #207053Net contents: 50 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2019-10-23
2 Ingredients (74)
IngredientGroupSafety
Vitamin B6Vitamin B6—
Vitamin B12Vitamin B12—
NickelNickel—
Microcrystalline CelluloseCellulose—
AcaciaAcacia—
GelatinGelatin—
Stearic AcidStearic Acid—
CrospovidoneCrospovidone—
HypromelloseHypromellose—
PolydextrosePolydextrose—
Polyethylene GlycolPolyethylene glycol—
Medium Chain TriglyceridesMedium chain triglycerides (MCT)—
FD&C Blue #2 Aluminum LakeColor—
FD&C Red #40 Aluminum LakeColor—
FD&C Yellow #5 Aluminum LakeColor—
Nickel SulfateNickel Sulfate—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Vitamin A — Conditionally Safe
⚠ Teratogenic at high doses
⚠ Hepatotoxic with chronic excess
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Vitamin D — Generally Safe
⚠ Hypercalcemia at >10,000 IU/day
⚠ Vascular calcification risk
Vitamin E — Conditionally Safe
⚠ Increased bleeding risk
⚠ All-cause mortality at >400 IU/day
Vitamin K — Conditionally Safe
⚠ Critical interaction with warfarin
Thiamine — Generally Safe
⚠ Very low toxicity
Riboflavin — Generally Safe
⚠ Harmless yellow urine
Niacin — Conditionally Safe
⚠ Flushing at >50 mg
⚠ Hepatotoxicity at high doses
Folate — Conditionally Safe
⚠ May mask B12 deficiency
⚠ Colorectal cancer risk debated
Biotin — Generally Safe
⚠ Interferes with troponin and thyroid lab assays
Pantothenic Acid — Generally Safe
⚠ Diarrhea at very high doses
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Iron — Conditionally Safe
⚠ GI upset, constipation
⚠ Fatal toxicity in children
Phosphorus — Generally Safe
⚠ Excess impairs calcium absorption
Iodine — Conditionally Safe
⚠ Thyroid dysfunction at excess
⚠ Kelp: variable content
Magnesium — Generally Safe
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Zinc — Conditionally Safe
⚠ Copper deficiency at >40 mg/day
⚠ Nausea, metallic taste
Selenium — Conditionally Safe
⚠ Selenosis >400 mcg
⚠ Diabetes risk at high doses
Copper — Conditionally Safe
⚠ Hepatotoxicity at high doses
Manganese — Conditionally Safe
⚠ Neurotoxicity with chronic excess
Chromium — Conditionally Safe
⚠ Hypoglycemia with diabetes meds
⚠ Rare renal/hepatic toxicity
Molybdenum — Generally Safe
⚠ Very low toxicity
Chloride — Generally Safe
⚠ Co-ingested with sodium
Potassium — Conditionally Safe
⚠ Hyperkalemia risk
⚠ Dangerous with ACE inhibitors
Silicon — Generally Safe
⚠ Very low toxicity
Vanadium — Limited Evidence
⚠ GI toxicity: nausea, vomiting, diarrhea
⚠ Green tongue
Lutein — Generally Safe
⚠ Harmless skin yellowing at very high doses
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Magnesium — Generally Safe
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Potassium — Conditionally Safe
⚠ Hyperkalemia risk
⚠ Dangerous with ACE inhibitors
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Vitamin E — Conditionally Safe
⚠ Increased bleeding risk
⚠ All-cause mortality at >400 IU/day
Sodium — Conditionally Safe
⚠ Hypertension
⚠ Fluid retention
Iron — Conditionally Safe
⚠ GI upset, constipation
⚠ Fatal toxicity in children
Zinc — Conditionally Safe
⚠ Copper deficiency at >40 mg/day
⚠ Nausea, metallic taste
Niacin — Conditionally Safe
⚠ Flushing at >50 mg
⚠ Hepatotoxicity at high doses
Titanium Dioxide — Limited Evidence
⚠ EFSA: can no longer be considered safe as food additive (2021)
⚠ Genotoxicity concern (nanoparticles)
Magnesium — Generally Safe
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Manganese — Conditionally Safe
⚠ Neurotoxicity with chronic excess
Silicon — Generally Safe
⚠ Very low toxicity
Pyridoxine — Conditionally Safe
⚠ Peripheral neuropathy at >200 mg/day chronically
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Thiamine — Generally Safe
⚠ Very low toxicity
Riboflavin — Generally Safe
⚠ Harmless yellow urine
Copper — Conditionally Safe
⚠ Hepatotoxicity at high doses
Vitamin A — Conditionally Safe
⚠ Teratogenic at high doses
⚠ Hepatotoxic with chronic excess
Vitamin A — Conditionally Safe
⚠ Teratogenic at high doses
⚠ Hepatotoxic with chronic excess
Chromium — Conditionally Safe
⚠ Hypoglycemia with diabetes meds
⚠ Rare renal/hepatic toxicity
Lutein — Generally Safe
⚠ Harmless skin yellowing at very high doses
Potassium — Conditionally Safe
⚠ Hyperkalemia risk
⚠ Dangerous with ACE inhibitors
Sodium — Conditionally Safe
⚠ Hypertension
⚠ Fluid retention
Vitamin K — Conditionally Safe
⚠ Critical interaction with warfarin
Sodium — Conditionally Safe
⚠ Hypertension
⚠ Fluid retention
Cobalamin — Generally Safe
⚠ Very low toxicity
Vitamin D — Generally Safe
⚠ Hypercalcemia at >10,000 IU/day
⚠ Vascular calcification risk
Sodium — Conditionally Safe
⚠ Hypertension
⚠ Fluid retention
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID207053
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2019-10-23
6 More from DG Health
View DG Health Safety Scorecard → 16 products
Adult Formula Complete 50+Advanced Formula CompleteAdvanced Formula CompleteAdvanced Formula CompleteCalcium 600 mg with Vitamin DCalcium 600 mg with Vitamin D7 Cite this page
Vancouver
Pkhakadze G. Complete for Women Over 50 — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 May 30]. Available from: https://supplement.ge/products/dsld-207053/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG